KKR & Co LP (KKR.N)

KKR.N on New York Stock Exchange

23.14USD
24 Dec 2014
Price Change (% chg)

$0.24 (+1.05%)
Prev Close
$22.90
Open
$22.99
Day's High
$23.30
Day's Low
$22.92
Volume
197,098
Avg. Vol
575,153
52-wk High
$26.48
52-wk Low
$18.84

KKR.N

Chart for KKR.N

About

KKR & Co. L.P. (KKR), incorporated on June 25, 2007, is a global investment company. The Company's business offers a broad range of investment management services to the Company's fund investors and provides capital markets services to its firm, its portfolio companies and other third parties. The Company conducts its business... (more)

Overall

Beta: 1.89
Market Cap (Mil.): $18,764.90
Shares Outstanding (Mil.): 810.93
Dividend: 0.46
Yield (%): 8.69

Financials

  KKR.N Industry Sector
P/E (TTM): 10.66 31.55 15.25
EPS (TTM): 2.17 -- --
ROI: 69.05 4.25 0.85
ROE: 18.89 3.91 22.70
Search Stocks

Madison Dearborn in the lead to take over Walgreen unit: sources

- Buyout firm Madison Dearborn Partners LLC is in advanced talks to acquire a majority stake in the infusion services business of U.S. drugstore chain operator Walgreen Co for more than $1 billion, according to two people close to the situation.

19 Dec 2014

REFILE-Madison Dearborn in the lead to take over Walgreen unit -sources

Dec 19 - Buyout firm Madison Dearborn Partners LLC is in advanced talks to acquire a majority stake in the infusion services business of U.S. drugstore chain operator Walgreen Co for more than $1 billion, according to two people close to the situation.

19 Dec 2014

KKR to invest in Arbor Pharmaceuticals: sources

- KKR & Co LP has agreed to acquire a significant minority stake in Arbor Pharmaceuticals LLC, in a deal that values the privately held specialty drugmaker at more than $1 billion, including debt, people familiar with the matter said on Thursday.

04 Dec 2014

KKR to invest in Arbor Pharmaceuticals -sources

Dec 4 - KKR & Co LP has agreed to acquire a significant minority stake in Arbor Pharmaceuticals LLC, in a deal that values the privately held specialty drugmaker at more than $1 billion, including debt, people familiar with the matter said on Thursday.

04 Dec 2014

Freepoint Commodities, KKR funding group team up to challenge Wall Street

NEW YORK - Trading firm Freepoint Commodities and a financing group including KKR & Co are joining forces to challenge Wall Street's long dominance of funding the raw materials industry.

04 Dec 2014

Freepoint Commodities, KKR funding group team up to challenge Wall St

NEW YORK, Dec 4 - Trading firm Freepoint Commodities and a financing group including KKR & Co are joining forces to challenge Wall Street's long dominance of funding the raw materials industry.

04 Dec 2014

KKR invests $100 million in arid climate agriculture firm

SYDNEY, Dec 4 - Private equity firm KKR & Co has invested about $100 million in UK-based agribusiness Sundrop Farms Holding Ltd, which plans to use solar panels and sea water to grow vegetables in a vast greenhouse in Australia's driest state.

03 Dec 2014

MOVES-KKR appoints Alejo Vidal-Quadras as director in Madrid office

Dec 1 - Private-equity firm KKR & Co LP appointed Alejo Vidal-Quadras as a director in its Madrid office, responsible for developing and supporting KKR's investment platforms in Spain.

01 Dec 2014

INDONESIA PRESS-Kohlberg Kravis, Bunge Agribusiness express interest in Golden Plantation-Investor Daily

Kohlberg Kravis Roberts & Co LP and Bunge Agribusiness Singapore Pte Ltd, have expressed interest in buying 88 percent shares of PT Golden Plantation, a unit of PT Tiga Pilar Sejahtera (TPS) Food Tbk, Investor Daily reported, citing TPS Food's Finance Director, Sjambiri Lioe.

24 Nov 2014

Exclusive: KKR, CD&R prepare joint bid for PetSmart: sources

NEW YORK - Buyout firms KKR & Co LP and Clayton, Dubilier & Rice LLC (CD&R) have teamed up to take PetSmart Inc private for more than $7.5 billion, people familiar with the matter said on Tuesday, as the auction for the pet food retailer heats up.

19 Nov 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks